Literature DB >> 458270

Modification of the fatty acid composition of cultured human fibroblasts.

A A Spector, R E Kiser, G M Denning, S W Koh, L E DeBault.   

Abstract

The fatty acid composition of human skin fibroblasts grown in 10% dialyzed fetal calf serum can be modified considerably by adding supplemental fatty acids to the culture medium. The degree of modification was dependent on the concentration of added fatty acid over the range tested, 2.5 X 10(-5) to 1 X 10(-4) M. At the higher concentration, the extent of the modifications was as those which can be produced in nonhuman or malignant cell lines. Although the greatest changes were produced in the neutral lipid fraction, the cellular phospholipids also exhibited appreciable modifications. The phospholipids isolated from a microsomal fraction prepared from the cell homogenate exhibited similar changes in fatty acyl composition. These findings indicate that the human fibroblast can tolerate considerable variability in fatty acid composition, even in membrane phospholipids. The triglyceride content of the cells increased when they were grown in the presence of added fatty acids, but the phospholipid and cholesterol content remained unchanged. Growth was not affected by either oleic or linoleic acids, but it was reduced up to 50% when palmitic linolenic, or arachidonic acid was added in concentrations of 5 X 10(-5) M or above. Extensive modifications in phospholipid fatty acid composition also were produced in confluent monolayers of these fibroblasts. This suggest that some membrane lipid turnover occurs even when the cultures are not rapidly growing. Fatty acid modifications also were produced in the commercially available IMR-90 strain of human lung fibroblasts, suggesting that the ability to tolerate considerable differences in fatty acid composition is not a special property of the skin fibroblast line that was isolated locally.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458270

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  Cultivation of HeLa cells with fetal bovine serum or Ultroser G: effects on the plasma membrane constitution.

Authors:  Y Blixt; A Valeur; E Everitt
Journal:  In Vitro Cell Dev Biol       Date:  1990-07

2.  Effects of membrane fatty acid composition on sodium-independent phenylalanine transport in Ehrlich cells.

Authors:  W B Im; J T Deutchler; A A Spector
Journal:  Lipids       Date:  1979-12       Impact factor: 1.880

3.  Lipid profiling of polarized human monocyte-derived macrophages.

Authors:  J Rafael Montenegro-Burke; Jessica A Sutton; Lisa M Rogers; Ginger L Milne; John A McLean; David M Aronoff
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-11-15       Impact factor: 3.072

4.  Utilization of polyunsaturated fatty acids by human diploid cells aging in vitro.

Authors:  R D Lynch
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

5.  Retention of human skin fibroblast fatty acid modifications during maintenance culture.

Authors:  A A Spector; G M Denning; L L Stoll
Journal:  In Vitro       Date:  1980-11

6.  Selectivity in incorporation, utilization and retention of oleic and linoleic acids by human skin fibroblasts.

Authors:  M D Rosenthal
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

7.  Fatty acid composition of serum lipids in fasting ponies.

Authors:  J E Bauer; W D Ransone
Journal:  Lipids       Date:  1983-06       Impact factor: 1.880

8.  Increased saturated phospholipid in cultured cells grown with linoleic acid.

Authors:  F B Smith; Y Kikkawa; C A Diglio; R C Dalen
Journal:  In Vitro       Date:  1982-04

9.  Accumulation of (n-9)-eicosatrienoic and docosatrienoic acids in human fibroblast phospholipids.

Authors:  S Karmiol; W J Bettger
Journal:  Lipids       Date:  1988-09       Impact factor: 1.880

10.  A comparison of the specificity of phosphatidylcholine synthesis by human fetal lung maintained in either organ or organotypic culture.

Authors:  P A Caesar; S J Wilson; C S Normand; A D Postle
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.